The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis

Molecular Nutrition and Food Research

Volumn 53, Issue 11, 2009, Pages 1419-1429

  Nizamutdinova, Irina Tsoy ^a   Jin, Yong Chun ^a   Chung II, Jong ^b   Shin, Sung Chul ^b   Lee, Sung Joong ^b   Seo, Han Geuk ^a   Lee, Jae Heun ^a   Chang, Ki Churl ^a   Kim, Hye Jung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Anthocyanins; Apoptosis; Diabetes; Glucose transporter4; Insulin receptor phosphorylation

Indexed keywords

ANTHOCYANIN; ANTIDIABETIC AGENT; GLUCOSE TRANSPORTER 4; SLC2A4 PROTEIN, RAT; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; BODY WEIGHT; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; INSULIN RESISTANCE; MALE; METABOLISM; OXIDATIVE STRESS; PANCREAS; PATHOLOGY; PHYSIOLOGY; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTHOCYANINS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TRANSPORTER TYPE 4; HEMODYNAMICS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; OXIDATIVE STRESS; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TRIGLYCERIDES;

GLYCINE MAX; RATTUS;

EID: 70449602358     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800526     Document Type: Article

References (44)

1. Ferrannini, E., Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev. 1998, 19, 477-490.
2. Kahn, S. E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003, 46, 3-19.
3. Gerich, J. E., Insulin resistance is not necessarily an essential component of type 2 diabetes. J. Clin. Endocrinol.Metab. 2000, 85, 2113-2115.
4. Florez, J. C., Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 2008, 51,1100-1110.
5. Thies, R. S., Molina, J. M., Ciaraldi, T. P., Freidenberg, G. R.Olefsky, J. M., Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes 1990,39,250-259.
6. Taylor, S. I., Deconstructing type 2 diabetes. Cell 1999, 97,9-12.
7. Zhang, B. B., Moller, D. E., New approaches in the treatment of type II diabetes. Curr. Opin. Chem. Biol. 2000, 4, 461-467
8. Salituro, G. M., Pelaez, F., Zhang, B. B., Discovery of a small molecule insulin receptor activator. Rec. Prog. Horm. Res.2001,56,107-126.
9. Haruta, T., Morris, A. J., Rose, D. W., Nelson, J. G. et al.Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J. Biol. Chem.1995,270,27991-27994.
10. Charron, M. J., Katz, E. B., Oslon, A. L., GLUT4 gene regulation and manipulation. J. Biol. Chem. 1999, 274, 3253-3256
11. Pessin, J. E., Thurmond, D. C., Elmendorf, J. S., Coker, K. J.Okada, S., Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location! J. Biol.Chem. 1999, 274, 2593-2596.
12. Bryant, N. J., Govers, R., James, D. E., Regulated transport of the glucose transporter GLUT4. Nature Rev. Mol. Cell Biol. 2002, 3, 267-277.
13. DeFronzo, R. A., Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 1999, 131, 281-303
14. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2003,26, S28-S32.
15. Inzucchi, S. E., Oral antihyperglycemic therapy for type 2 diabetes. J. Am. Med. Assoc. 2002, 287, 360-372.
16. Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T. et al.Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.Diabetes 1999, 48, 2398-2406.
17. Virag, L., Marmer, D. J., Szabo, C., The crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation. Free Radic. Biol. Med. 1998, 25, 1075-1082
18. Yamada, K., Nonaka, K., Hanafusa, T., Miyazaki, A. et al.Preventive and therapeutic effects of large dose nicotina-mide injections on diabetes associated with insulitis.Diabetes 1982, 31, 749-753.
19. Taylor, B. H., Environmental and Chemical Evaluation of Variations in Hilum and Seed Coat Colors in Soybean. M.S.Thesis, University of Arkansas, Fayetteville, AR 1976.
20. Yoshida, K., Sato, Y., Okuno, R., Kameda, K. et al., Structural analysis and measurement of anthocyanins from colored seed coats of Vigna, Phaseolus, and Glycine Legumes.Biosci. Biotechnol. Biochem. 1996, 60, 589-593.
21. Choung, M. G., Baek, I. Y., Kang, S. T., Han, W. Y. et al.Isolation and determination of anthocyanins in seed coats of black soybean (Glycine max (L.) Merr). J. Agric. Food Chem. 2001, 49, 5848-5851.
22. Renaud, S., de Logeril, M., Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992,339,1523-1526.
23. Kim, H. J., Tsoy, I., Park, J. M., Chung, J. I. et al., Antho-cyanins from soybean seed coat inhibit the expression of TNF-a-induced genes associated with iischemia/reperfusion in endothelial cell by NF-kB-dependent pathway and reduce rat myocardial damages incurred by ischemia and reper-fusion in vivo. FEBS Lett. 2006, 580, 1391-1397
24. Burns, J., Gardner, P. T., O'Neil, J., Crawford, S. et al.Relationship among antioxidant activity, vasodilation capacity and phenolic contents of red wines. J. Agric. Food Chem. 2000, 48, 220-230.
25. Jayaprakasam, B., Vareed, S. K., Olson, L. K., Nair, M. G., Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J. Agric. Food Chem. 2005, 53, 28-31
26. Sasaki, R., Nishimura, N., Hoshino, H., Isa, Y. et al., Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol. 2007, 74,1619-1627.
27. Casis, O., Echevarria, E., Diabetic cardiomyopathy: electro-mechanical cellular alterations. Curr. Vasc. Pharmacol.2004,2,237-248.
28. Retnakaran, R., Zinman, B., Type 1 diabetes, hyperglycaemia, and the heart. Lancet 2008, 371, 1790-1799
29. Yki-Jarvinen, H., Glucose toxicity. Endocr. Rev. 1992, 13,415-431.
30. Stamler, J., Stamler, R., Brown, W. V., Gotto, A. M. et al.Serum cholesterol. Doing the right thing. Circulation 1993,88,1954-1960.
31. Palmieri, V., Capaldo, B., Russo, C., Iaccarino, M. et al.Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation.Diabetes Res. Clin. Pract. 2008, 79, 262-268.
32. Griffin, K. A., Abu-Naser, M., Abu-Amarah, I., Pichen, M.et al.Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes. Am. J. Physiol.Renal Physiol. 2007, 293, 1605-1613.
33. Tsoyi, K., Park, H. B., Kim, Y. M., Chung, J. I. et al., Anthocyanins from black soybean seed coats inhibit UVB-induced inflammatory cylooxygenase-2 gene expression and PGE2 production through regulation of the nuclear factor-kappaB and phosphatidylinositol 3-kinase/Akt pathway. J. Agric.Food Chem. 2008, 56, 8969-8974.
34. Buse, J. B., Yasuda, K., Lay, T. P., Seo, T. S. et al., Human GLUT4/muscle-fat glucose transporter gene. Characterization and genetic variation. Diabetes 1992, 41, 1436-1445.
35. Ezaki, O., Regulatory elements in the insulin-responsive glucose transporter (GLUT4) gene. Biochem. Biophys. Res.Commun. 1997, 241, 1-6.
36. Ni. G., Wang, N., Cao, D. J., Sachan, N. et al., FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc. Natl.Acad. Sci. USA 2007, 104, 20517-20522.
37. Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D. et al.Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 2000, 6, 924-928.
38. Futura, M., Yano, Y Gabazza, E. C., Araki-Sasaki, R. et al.Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.Diabetes Res. Clin. Pract. 2002, 56, 159-171.
39. Goldfine, I. D., The insulin receptor: molecular biology and transmembrane signaling. Endocrin. Rev. 1987, 8, 235-255.
40. Moller, D. E., Flier, J. S., Insulin resistance: Mechanisms,syndromes and implications. New Eng. J. Med. 1991, 325,938-948.
41. Kahn, C. R., Banting Lecture. Insulin action, diabetogenes,and the cause of type 2 diabetes. Diabetes 1994, 43,1066-1084.
42. Aragno, M., Mastrocola, R., Catalano, M. G., Brignardello, E.et al., Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 2004, 53, 1082-1088.
43. Augstein, P., Elefanty, A. G., Allison, J., Harrison, L.C.Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophospha mide-accelerated diabetes. Diabetologia 1998, 41,1381-1388.
44. Sigiura, M., Ohshima, M., Ogawa, K., Yano, M., Chronic administration of stasuma mandarin fruit (Citrus unshiu MARC.) improves oxidative stress in streptozotocin-induced diabetic rat liver. Biol. Pharm. Bull. 2006, 29, 588-591.